KYMERA THERAPEUTICS, INC. (KYMR) Total liabilities 2019–2025
KYMERA THERAPEUTICS, INC. (KYMR) total liabilities at each fiscal year-end, per SEC filings.
$163.1MFY2025 · since FY2019: $82.0M → $163.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $163.1M | +14.6% |
| FY2024 | $142.4M | -21.2% |
| FY2023 | $180.8M | +60.0% |
| FY2022 | $113.0M | -22.8% |
| FY2021 | $146.3M | -28.0% |
| FY2020 | $203.3M | +147.8% |
| FY2019 | $82.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More KYMR financial trends
KYMR RevenueKYMR Net incomeKYMR Net marginKYMR Gross profitKYMR Gross marginKYMR Operating incomeKYMR Operating marginKYMR Operating cash flowKYMR Free cash flowKYMR Capital expendituresKYMR Return on equityKYMR Stock buybacksKYMR Dividends paidKYMR Total assetsKYMR Shareholders’ equityKYMR overview →